In the TCGA gastric adenocarcinoma cohort, we examined the prognostic value of MPO and explored its potential pathogenic mechanisms through immune microenvironment and functional enrichment analyses, thereby providing a theoretical basis for MPO as a potential biomarker and therapeutic target in gastric mucosal injury and gastric adenocarcinoma. This evidence concerns the gene MPO and gastric adenocarcinoma.